XYMOGEN Artriphen Recalled for Undeclared Soy and Milk Allergens
XYMOGEN Artriphen joint supplement is being recalled because the label fails to declare soy and milk, posing a risk to allergic consumers.
The agency’s classification
FDA (Food): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Undeclared Soy and Milk on the label."
Plain-English summary
Atlantic Pro Nutrients, Inc. dba XYMOGEN is recalling 16,268 units of XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen, 90 and 180 capsule bottles. The recall is due to undeclared soy and milk on the product label.
The affected product was distributed in AK, AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, NJ, NM, NY, OH, OK, PA, RI, SC, TN, TX, UT, VA, WA, WI, WV, WY, District of Columbia, and Hawaii. All SKUs are included in this recall.
Consumers with allergies to soy or milk should not use this product. Individuals should check their inventory for this specific product and dispose of it or return it to the point of purchase.
The recalled product
- Product
- XYMOGEN EP Exclusive Patented Dietary Supplement Artriphen Clinically Tested to Support Healthy Joint Function, 90 and 180 capsule bottles
- Manufacturer
- Atlantic Pro Nutrients, Inc. dba XYMOGEN
- Category
- Food — Dietary Supplement
- Affected units
- 16,268
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All SKUs
Distribution
Related recalls
Same manufacturer · Atlantic Pro Nutrients, Inc. dba XYMOGEN
See all →- ModerateXYMOGEN Recalls LipiChol 540 Medical Food Due to Mislabeling
FDA (Food) · 2014-01-08
- LowXYMOGEN LipiChol Medical Food Recalled for Incorrect Product Classification
FDA (Food) · 2014-01-08
Same hazard · allergen soy
See all →- HighSaint Francis Apizza Frozen Cheese Pizza Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighSaint Francis Apizza Frozen Mushroom and Onion Pizza Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighSaint Francis Apizza Frozen Supreme Pizza Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighSaint Francis Apizza Frozen Pepperoni Pizza Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
- HighJ K Patisserie Chocolate Chip Cookies Recalled for Undeclared Soy
FDA (Food) · 2026-10-14
Similar recalls
- HighReaction Nutrition Recalls Bio Armor Glutamine Supplements Due to Allergen Mislabeling
FDA (Food) · 2015-06-17
- LowXYMOGEN LipiChol Medical Food Recalled for Incorrect Product Classification
FDA (Food) · 2014-01-08
- SevereNatureAll Acidophilus-Plus Recalled for Undeclared Milk Allergens
FDA (Food) · 2017-08-23
- SeverePronutri Tropical Orange Dietary Supplement Recalled for Undeclared Allergens
FDA (Food) · 2016-06-08
- HighDietary Supplements Recalled for Undeclared Soy Allergen
FDA (Food) · 2020-08-12
- HighMTN OPS MULTI-V Men's Daily Multivitamin dietary supplement recall undeclared soy
FDA (Food) · 2025-04-16